Literature DB >> 20882567

Sp1 phosphorylation is involved in myelin basic protein gene transcription.

Lili Guo1, Tamar Eviatar-Ribak, Robin Miskimins.   

Abstract

Myelin basic protein (MBP), which helps form compact myelin sheets, is a major protein expressed during oligodendrocyte (OL) differentiation. Myelin basic protein expression is regulated mainly at the transcriptional level. Previous studies showed that the transcription factor Sp1 can activate the MBP promoter. Data from the laboratory also indicate that Sp1 is expressed highly in both growing and differentiated cells. Because this is true, we wanted to understand how Sp1 activity is regulated such that it increases MBP gene transcription only in differentiating cells. Phosphorylation is one major way to regulate transcription factor activity. Our results show that there is more Sp1 binding to the MBP promoter in differentiating OLs. Sp1 is also more phosphorylated in differentiating OLs than in precursor cells. Using inhibitors of different pathways, we found that the protein kinase C (PKC) modulator phorbol 12-myristate 13-acetate (PMA) can increase Sp1 phosphorylation when the cells are treated for 1 hr and can decrease Sp1 phosphorylation with long treatment (12 hr). The increased phosphorylation of Sp1 induced by PMA in short treatments could be abolished by the extracellular signal-regulated kinases (ERK) pathway inhibitor PD98059. This indicates that PKC phosphorylates Sp1 through the ERK pathway. Mutation of Sp1 threonines 453 and 739, which are phosphorylated by ERK, decreased MBP transcriptional activity. Furthermore, we found that PKC regulates Sp1 phosphorylation only in differentiating OLs. In conclusion, our results indicate that, in OLs, Sp1 phosphorylation can be regulated by PKC-ERK pathways. This phosphorylation is important for MBP transcription and oligodendrocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20882567     DOI: 10.1002/jnr.22486

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Inhibition of TROY promotes OPC differentiation and increases therapeutic efficacy of OPC graft for spinal cord injury.

Authors:  Liang Sun; Shengliang Liu; Qi Sun; Zhuying Li; Fengyan Xu; Chunmei Hou; Toshihide Harada; Ming Chu; Kun Xu; Xiaoling Feng; Yongshun Duan; Yafang Zhang; Shuliang Wu
Journal:  Stem Cells Dev       Date:  2014-06-16       Impact factor: 3.272

2.  Leukemia/lymphoma-related factor (LRF) exhibits stage- and context-dependent transcriptional controls in the oligodendrocyte lineage and modulates remyelination.

Authors:  Nathan L Davidson; Fengshan Yu; Naruchorn Kijpaisalratana; Tuan Q Le; Laurel A Beer; Kryslaine L Radomski; Regina C Armstrong
Journal:  J Neurosci Res       Date:  2017-05-30       Impact factor: 4.164

3.  Role of Calcium Signaling Pathway-Related Gene Regulatory Networks in Ischemic Stroke Based on Multiple WGCNA and Single-Cell Analysis.

Authors:  Weiwei Lin; Yangxin Wang; Yisheng Chen; Qiangwei Wang; Zhaowen Gu; Yongjian Zhu
Journal:  Oxid Med Cell Longev       Date:  2021-12-26       Impact factor: 6.543

4.  Cloning and characterization of the human USP22 gene promoter.

Authors:  Jianjun Xiong; Xiangxin Che; Xueqin Li; Huan Yu; Zhen Gong; Weidong Li
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

5.  Shenzhiling oral solution promotes myelin repair through PI3K/Akt-mTOR pathway in STZ-induced SAD mice.

Authors:  Gaofeng Qin; Yahan Wang; Zhenhong Liu; Lulu Mana; Shuaiyang Huang; Pengwen Wang
Journal:  3 Biotech       Date:  2021-07-01       Impact factor: 2.893

6.  Identification of a truncated kinase suppressor of Ras 2 mRNA in sperm.

Authors:  Lili Guo; Deanna J Volle; Robert E Lewis
Journal:  FEBS Open Bio       Date:  2014-04-21       Impact factor: 2.693

7.  CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation.

Authors:  David Kremer; Qiao-Ling Cui; Peter Göttle; Tanja Kuhlmann; Hans-Peter Hartung; Jack Antel; Patrick Küry
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.